Research Advances of The NLRP3 Inflammasome and Metabolic Disease
DOI:
Author:
Affiliation:

University of South China,University of South China,University of South China,University of South China,University of South China,University of South China

Clc Number:

Fund Project:

This work was supported by grants from The National Natural Science Foundation of China (81100213), The Innovation Foundation for Postgraduate of Hunan Province (2012SCX13), The National College Students' Innovation and Entrepreneurship Training Program (201210555018)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Metabolic diseases are caused by amino acid, glucose and lipid metabolism disorder, chronic inflammation is one of its important characteristics. The Nod-like receptor protein 3 (NLRP3) inflammasome is a protein complexes located in cellular, the main function is to activate caspase -1, and then to indirectly regulate the mature and secretion of interleukin 1β (IL-1β), IL-18 and IL-33. The NLRP3 inflammasome is a hotspot in inflammasome associated studies, a variety of endogenous or exogenous danger signals up-regulated the expression of inflammatory cytokines through the activation of this protein complex, and promoted the occurrence and development of many metabolic diseases. Here we reviewed the structure, function and the regulation of the NLRP3 inflammasome, then discussed its role in metabolic diseases, in order to provide the new targets for the prevention and treatment of metabolic diseases.

    Reference
    Related
    Cited by
Get Citation

LI Jin-Feng, XIE Di, HE Ping-Ping, TANG Yan-Yan, TU Yu-Lin, YIN Kai. Research Advances of The NLRP3 Inflammasome and Metabolic Disease[J]. Progress in Biochemistry and Biophysics,2014,41(5):425-434

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 18,2013
  • Revised:August 26,2013
  • Accepted:August 29,2013
  • Online: May 22,2014
  • Published: May 20,2014